Ligandrol (LGD-4033)

Ligandrol LGD-4033 (VK5211) Ligandrol is an investigational selective androgen receptor modulator (SARM) for treatment of conditions such as muscle wasting and osteoporosis, discovered by Ligand Pharmaceuticals and currently under development by Viking Therapeutics.
LGD-4033, known also as Ligandrol and Anabolicum, is the strongest orally bioavailable, non-steroidal, selective androgen receptor modulator (SARM) currently on the market.
Popular with athletes, powerlifters, and bodybuilders for its ability to both bulk and cut, Ligandrol produces steroid-like results without the side effects.
It’s considered an excellent supplement for those looking to recomp: reduce their body fat and increase lean muscle mass.
From a medical perspective, Ligandrol is being studied to treat conditions such as muscle wasting linked with acute and chronic diseases, age-related muscle loss, Osteoporosis, and cancer.